Quince Therapeutics, Inc.QNCXNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-35.98M
↑ 16% above average
Average (7y)
$-42.96M
Historical baseline
Range
High:$-10.32M
Low:$-89.97M
CAGR
+19.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-35.98M | -34.2% |
| 2023 | $-26.82M | +47.4% |
| 2022 | $-50.99M | +43.3% |
| 2021 | $-89.97M | -14.5% |
| 2020 | $-78.56M | -101.5% |
| 2019 | $-38.98M | -223.0% |
| 2018 | $-12.07M | -16.9% |
| 2017 | $-10.32M | - |